Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Pozzilli

Showing results (211-220 of 247) with videos related to

Pageof 25
Sort By:
Journal of Neurology|August 23, 2024
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimodAntonio Carotenuto, Cristina Di Monaco, Laura Papetti, et al.
Neurology|February 14, 2018
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risksEmilio Portaccio, Lucia Moiola, Vittorio Martinelli, et al.
BMC Neurology|October 24, 2012
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric studyMarta Giannini, Emilio Portaccio, Angelo Ghezzi, et al.
Journal of Neurology|August 23, 2024
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosisMarta Simone, Giuseppe Lucisano, Tommaso Guerra, et al.
BMC Neurology|January 2, 2013
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort studyLuisa Pastò, Emilio Portaccio, Angelo Ghezzi, et al.
CNS Drugs|July 20, 2018
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World StudyMassimiliano Mirabella, Luca Prosperini, Matteo Lucchini, et al.
Neurology|February 14, 2018
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risksEmilio Portaccio, Pietro Annovazzi, Angelo Ghezzi, et al.
Neurology|June 17, 2016
Assessing response to interferon-β in a multicenter dataset of patients with MSMaria Pia Sormani, Claudio Gasperini, Marzia Romeo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 yearsEmilio Portaccio, Luisa Pastò, Lorenzo Razzolini, et al.
Journal of Clinical Medicine|March 29, 2023
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and DepressionCristiano Scandurra, Laura Rosa, Antonio Carotenuto, et al.
Pageof 25

Showing results (211-220 of 247) with videos related to

Sort By:
Pageof 25
Journal of Neurology|August 23, 2024
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimodAntonio Carotenuto, Cristina Di Monaco, Laura Papetti, et al.
Neurology|February 14, 2018
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risksEmilio Portaccio, Lucia Moiola, Vittorio Martinelli, et al.
BMC Neurology|October 24, 2012
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric studyMarta Giannini, Emilio Portaccio, Angelo Ghezzi, et al.
Journal of Neurology|August 23, 2024
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosisMarta Simone, Giuseppe Lucisano, Tommaso Guerra, et al.
BMC Neurology|January 2, 2013
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort studyLuisa Pastò, Emilio Portaccio, Angelo Ghezzi, et al.
CNS Drugs|July 20, 2018
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World StudyMassimiliano Mirabella, Luca Prosperini, Matteo Lucchini, et al.
Neurology|February 14, 2018
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risksEmilio Portaccio, Pietro Annovazzi, Angelo Ghezzi, et al.
Neurology|June 17, 2016
Assessing response to interferon-β in a multicenter dataset of patients with MSMaria Pia Sormani, Claudio Gasperini, Marzia Romeo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 yearsEmilio Portaccio, Luisa Pastò, Lorenzo Razzolini, et al.
Journal of Clinical Medicine|March 29, 2023
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and DepressionCristiano Scandurra, Laura Rosa, Antonio Carotenuto, et al.
Pageof 25